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Antibiotic prophylaxis in the prevention of urinary tract 
infection in patients with sterile urine before 
extracorporeal shock wave lithotripsy 
 
Abstract 
Background: One of the lithotripsy complications is urinary tract infection (UTI) and 
sepsis after extracorporeal shock wave lithotripsy (ESWL). The aim was to study the 
prophylactic effect of antibiotics on UTI after ESWL. 
Methods: This randomized double-blind clinical trial was carried out on 600 patients 
admitted to Babol Clinic hospital in 2014-2015. Patients were randomly divided into 
treatment group (receiving 200 mg ofloxacin and control group (receiving placebo. The 
effect of prophylactic antibiotics on the incidence of bacteriuria after ESWL and the 
impact of variables such as gender, age, urolithiasis size and location and underlying 
diseases in the incidence of UTI after ESWL were evaluated. 
Results: Totally, 67 of the population had positive urine cultures. Twenty-nine (10.13%) 
of them were in the treatment group (n=286) and 38 (13.01%) of them were in the control 
group (n=292). All 67 patients had asymptomatic bacteriuria. Escherichia coli and proteus 
were the grown microorganisms in most samples. The mean age of sample population was 
44.8±23, and 67.16% of patients with positive urine culture were older than 45 years. 
Conclusions: The results indicated that prophylactic antibiotics prior to ESWL in patients 
with urinary calculi and negative urine culture had no significant decrease in urinary tract 
infection after lithotripsy. It is better that the use of prophylactic antibiotics is limited to 
patients with risk factors. 
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Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive method for the 
treatment of urolithiasis and choledocholithiasis using acoustic waves (1, 2). One of the 
side effects of this method is urinary tract infection (UTI) after lithotripsy and sepsis in 
severe cases (3, 4). There are several studies in different countries regarding the incidence 
of UTI after lithotripsy and the use of antibiotic prophylaxis, which have no consensus on 
the use of antibiotic prophylaxis. American Urological Association (AUA) states that the 
use of prophylactic antibiotics is necessary based on the patient's condition or the type of 
surgery resulting in UTI (5), while European Association of Urology (EAU) believes that 
the use of prophylactic antibiotics is necessary only for proven prostate biopsy and 
transurethral resection of the prostate (TURP) (6). Therefore, the aim of the current study 
was to evaluate the efficacy of prophylactic antibiotics in patients undergoing lithotripsy 
and study the risk factors predisposing to UTI after lithotripsy.  
 
Methods 
This randomized double-blind clinical trial was approved by the Ethics Committee of 
Babol University of Medical Sciences (IRCT201506242897N1).   
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Sampling was done during nine months, from December 
2014 to August 2015. The sample consisted of 600 patients 
who referred to Babol Clinic hospital after the diagnosis of 
urolithiasis using kidney, ureter and bladder (KUB) to break 
up stones. Inclusion criteria were; patients with the age of 18 
years or older, negative urine culture before ESWL (<10
5
 
bacterial colonies per ml), the absence of a foley catheter or 
nephrostomy tube. Patients were randomly divided into two 
groups (treatment and control). The treatment group received 
ofloxacin tablets (200 mg/12 h/3 days) after operation and 
the control group took placebo made of flour. Two weeks 
after ESWL, ultrasound was performed to examine the 
remains of the detectable stones for all patients. Information 
related to the symptomatic UTI was recorded.  
Twenty-two patients who did not refer for urine culture 
two weeks after ESWL or who had endourological 
manipulations during and after ESWL were excluded from 
the present study. Finally, data were analyzed using SPSS16 
through statistical tests such as multivariate chi-square, 
logistic regression and t-test.  
 
 
Results 
According to the results of urine culture performed two 
weeks after the operation, 67 of the population had positive 
urine culture. Twenty-nine (10.13%) and 38 (13.01%) of 
these 67 patients were in treatment and control groups 
(P=0.082), respectively. All 67 patients had asymptomatic 
bacteriuria without urosepsis. Escherichia coli and proteus 
were the grown microorganisms in most samples. The mean 
age of sample population was 44.8±23 years and 67.16% of 
patients with positive urine culture were older than 45 years. 
In addition, 19.4% of patients with positive urine culture had 
underlying disease of diabetes and 20.8% of them had a 
history of UTI (p=0.03, 0.015, respectively). Moreover, 
29.8% patients with positive urine culture had a history of 
the transurethral lithotomy (TUL) and surgeries of the 
urinary system within 5 years. Nevertheless, there was no 
significant relationship between hypertension, a history of 
TUL and TURP with bacteriuria. Male to female ratio was 4 
to 5 in patients with positive urine culture. Averagely, the 
location of urolithiasis in 46.2% of patients with positive 
urine culture was in kidney (P=0.11). Furthermore, 58.2% of 
patients with positive urine culture had urinary stones with a 
diameter of 10-19 mm and 19.4% of patients with urinary 
stones greater than 20 mm in diameter. There was a 
significant relationship between bacteriuria after lithotripsy 
and a diameter of urolithiasis (p=0.013). Moreover, the risk 
factors were diabetes (p=0.004), stone size (p=0.03) and age 
(66-85, p=0.011). 
 
 
Discussion  
In the current study, the incidence of bacteriuria was 
10.13% and 13.01% in the treatment and control groups, 
respectively. The incidence of bacteriuria after ESWL was 
generally low in patients and the use of antibiotic 
prophylaxis had no significant difference to reduce the 
incidence of bacteriuria after ESWL. In a study of Moreno et 
al., culture was positive in 8.5% of patients 7 days after 
ESWL, so 2.1% of these patients were symptomatic and the 
rest were asymptomatic. They did not use any antibiotics in 
their study so the statistical results of both studies could not 
be compared in terms of the effect of prophylactic antibiotics 
(7). Infectious complications were found in 1/3% of patients 
in a study of Honey et al. who assessed the need of antibiotic 
prophylaxis before ESWL (8). Therefore, it is clear that 
antibiotic prophylaxis before ESWL is not necessary in 
patients without risk factors and with negative urine culture. 
The effect of prophylaxis antibiotic is debatable in male 
elderly patients. Bacteriuria after ESWL was higher in men 
over 45 years in the present study, which differs from the 
result of Alexander Cameron et al. in terms of gender and 
resembles their result in terms of age. Bacteriuria was higher 
in women and older patients in their study (9). 
One reason for the high incidence of bacteriuria in 
elderly men in our study was the high number of men in both 
groups. Moreover, the high probability of benign prostatic 
hypertrophy and its role in urinary stasis in creating fertile 
ground for bacteriuria in older men can be reasonable causes 
in the present study.  
To avoid these complications, some strategies such as 
removing the previous underlying disease, early treatment of 
UTI, using prophylaxis antibiotic and reducing the number 
and energy of shock waves had been proposed (10). Their 
results of the determination of underlying diseases including 
previous UTI as a risk factor for creating UTI after ESWL 
and the need of antibiotic prophylaxis in patients with risk 
factors are similar to those of the current study. In the current 
study, in terms of the location of urinary calculi and its role 
in the incidence of bacteriuria after ESWL, it was concluded 
that in the majority of patients in both groups, the location of 
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stone was in kidney and upper ureter, but the role of stone 
location has not been proven in the incidence of bacteriuria 
yet. In terms of stone size and its role in the incidence of 
bacteriuria after ESWL in the present study, it was suggested 
that the diameter of urolithiasis was between 11-19 mm in 
the majority of patients (58.2%) and the highest incidence of 
bacteriuria after ESWL was observed in patients with stones 
over 11 mm. Moreno et al. on evaluating the risk factor of 
stone size showed that the rate of bacteriuria after ESWL 
was higher in patients with greater diameter of stone (7). The 
higher incidence of bacteriuria in larger stones can be 
attributed to the high number of crushed stones after ESWL 
and more likely of creating minor damages on the 
endothelial surfaces by crushed stones and release of higher 
levels of bacteria of stones. In several studies, it was 
suggested that the use of antibiotic prophylaxis had little 
effect on preventing from the incidence of bacteriuria after 
lithotripsy; therefore, an appropriate use of antibiotics can 
not only reduce the drug complications but also prevent the 
resistance of organisms against these drugs (9, 11-13). 
In conclusion, the results of the current study suggested 
that the rate of infectious complications after ESWL had no 
significant reduction with the use of prophylactic antibiotics 
and generally, infectious complications were higher in older 
men and those with a history of diabetes, UTI and stones 
larger than 10 mm in upper ureteral. The use of prophylactic 
antibiotics is recommended in patients with one or more 
mentioned risk factors. 
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